Published by Josh White on 4th May 2022
(Sharecast News) - Specialist drug discovery and development company ImmuPharma said on Wednesday that final preparations were now underway to progress 'Lupuzor' into its new, optimised international phase 3 trial in lupus patients.
URL: http://www.digitallook.com/dl/news/story/32651201/...